Healthcare Global Enterprises Limited — Important, 11-03-2025: General Updates
HealthCare Global Enterprises Limited (HCG), a public limited company focused on oncology services, is undergoing an open offer initiated by Hector Asia Holdings II Pte. Ltd., along with its associated entities, to acquire up to 3,70,90,327 equity shares, representing 26% of HCG's expanded voting share capital, at a price of INR 504.41 per share. This acquisition results from an SPA, which mandates that the acquirer obtains significant control over HCG.
The proposed timeline for the offer indicates that the tendering period will run from April 23 to May 7, 2025, and shareholders may participate whether their shares are in dematerialized or physical form. The financial arrangements include a cash escrow amount of INR 18.71 crore, with a bank guarantee of INR 262.10 crore ensuring obligations under the open offer.
Stakeholders should note that this offer is not subject to minimum acceptance conditions. The acquirer intends to maintain HCG's business direction post-offer, presenting potential growth opportunities for investors. Hence, all public shareholders are encouraged to evaluate their participation within the defined timelines.
All announcements from Healthcare Global Enterprises Limited
